Improving Radiation Therapy for Cancer

with ProACTive^TM (U.S. Patent # 7197404)

AppCompTech is a software development company focused on a life sciences application in Radiation Treatment Planning for Cancer Therapy. In 2008 an estimated 1.4 million Americans will be diagnosed with cancer and approximately 65% of those cancer victims will receive some form of radiation therapy.

Our patented technology/software, called ProACTive™, shatters today’s industry-wide speed barrier to high accuracy dose calculation for radiation therapy. We blend incredible speed with accuracy, enabling adaptive planning for a significant competitive advantage over existing treatment technology. Adaptive planning with ProACTive can offer:

• Better accuracy

• Better outcomes 

• Fewer complications

• Increased patient throughput

• Lower medical costs
  

.